drugset / Trial / NCT00826163
Innate Immune Responses in Chronic Obstructive Pulmonary Disease (COPD) Patients
Phase 3
Completed
20 enrolled
Mahidol University
National Science and Technology Development Agency, Thailand · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
We hypothesize that ongoing and more severe airway inflammation in COPD may result from the impairment in activation of innate immune response
Timeline
- Start
- 2009-01
- Primary completion
- 2009-11
- Completion
- 2009-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Budesonide | Small molecule | 400 ug | Inhaled |